首頁 > 市場調查報告書 > 醫療設備

手術用器具

市場調查報告書

商品編碼

1618266

吻合設備:市場洞察·競爭環境·市場預測 (～2030年)

Anastomosis Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年12月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

在 2024 年至 2030 年的預測期內，吻合設備市場預計將以 5.3% 的複合年增長率成長。

由於結直腸癌和冠狀動脈疾病 (CAD) 患者數量的增加、監管部門的批准以及手術負擔的增加，吻合裝置市場正在經歷顯著增長，預計在預測期內將加速增長。

吻合裝置：市場動態

根據2024年全球癌症觀察站的數據，2022年全球大腸癌患者人數約為1,926,425人。其中，估計有 966,399 人來自亞洲，幾乎佔總數的 50%，538,262 人來自歐洲。全球大腸直腸癌的高盛行率正在推動手術治療的需求，而吻合裝置在腸道切除和重新連接中發揮重要作用。這些設備提高了手術精度，減少了併發症，並改善了患者的治療效果，這使得它們對於大腸癌手術和增加其市場佔有率至關重要。

根據英國心臟基金會的全球心臟和循環系統疾病情況說明書（2024 年），目前全球約有 2 億人患有 CAD。吻合裝置可提高冠狀動脈繞道手術 (CABG) 等手術的準確性和效率，改善患者預後並減少併發症，在 CAD 治療中變得越來越重要。

按產品劃分，外科縫合器領域預計將在 2023 年佔據較大的收入佔有率。這主要是由於製造商對開發先進的外科縫合器以實現有效的血管連接以及該行業提供的各種其他好處越來越感興趣。

外科縫合器為患有心血管和胃腸道疾病的患者帶來好處，包括快速部署、最小的組織反應、低感染風險和牢固的傷口閉合。吻合器也有各種形狀和尺寸，以方便手術過程中的閉合過程。

本報告提供全球吻合設備的市場調查，彙整市場概要，市場影響因素及市場機會分析，法律制度，市場規模的轉變·預測，各種區分·地區/各主要國家的詳細分析，競爭情形，主要企業簡介等資訊。

各產品
- 外科用縫合器
- 外科用縫合線
- 外科用密封膠
- 外科用黏劑
實用性
- 拋棄式
- 可重複使用
各用途
- 心血管外科
- 消化器官外科
- 其他
各終端用戶
- 醫院·診療所
- 門診病人手術中心
各地區
- 北美
- 歐洲
- 亞太地區
- 其他地區

第8章吻合設備市場:企業·產品簡介

B. Braun Melsungen AG
Intuitive Surgical
BAXTER
CryoLife, Inc
Johnson & Johnson Services, Inc.
Medtronic
Sinolinks Medical Innovation, Inc.
microcuremed
BIOWIN PHARMACEUTICAL CO., LIMITED
Waston Medical Corporation
W. L. Gore & Associates, Inc.
Hangzhou Demo Medical Technology Co., Ltd
BD
Dolphin Sutures
gpcmedical
Golden Stapler Surgical Co., Ltd.
JIANGSU JOYMED TECH CO., LTD
Changzhou Haiers Medical Devices Co., Ltd
Shanghai MedEco Industry Co., Ltd
ChangZhou WeiPu Medical Devices CO., LTD

第9章 KOL的見解

第10章計劃的方法

第11章關於DelveInsight

第12章免責聲明·聯絡方式

簡介目錄圖表

Product Code: DIMDCL0643

Anastomosis Device Market by Product (Surgical Staplers, Surgical Sutures, Surgical Sealants, and Surgical Adhesives), Usability (Disposable and Reusable), Application (Cardiovascular Surgery, Gastrointestinal Surgery, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing instances of chronic disorders and the rising product developmental activities worldwide

The anastomosis devices market is projected to grow at a 5.3% CAGR during the forecast period from 2024 to 2030. The anastomosis devices market is growing significantly due to the increasing cases of colorectum cancers, coronary artery disease (CAD) among the population, clearances from regulatory bodies, and the growing burden of surgeries are factors that are expected to escalate the overall growth of the anastomosis devices market during the forecast period from 2024 to 2030.

Anastomosis Devices Market Dynamics:

Data from the Global Cancer Observatory 2024, stated that in the year 2022 there were about 1926425 total colorectum cancer cases worldwide. The same source further stated that Asia accounted for 966399 colorectum cancer cases, comprising almost 50% of the total cases, and Europe accounted for 538262 colorectum cancer cases. The high incidence of colorectal cancer globally drives the demand for surgical treatments, where anastomosis devices play a critical role in resecting and reconnecting the colon. These devices enhance surgical precision, reduce complications, and improve patient outcomes, making them indispensable in colorectal cancer surgeries and expanding their market presence.

According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people are currently living with CAD around the world. Anastomosis devices enhance precision and efficiency in procedures like coronary artery bypass grafting (CABG), improving patient outcomes and reducing complications, making them increasingly integral to CAD treatment.

Increased product development activities by regulatory bodies are also slated to witness market growth for anastomosis devices. For example, in January 2023, Lydus Medical announced that its Vesseal microvascular anastomosis suture deployment system received 510(k) clearance from the US Food and Drug Administration (FDA).

Hence, the interplay of all the above-mentioned factors are expected to drive the market for anastomosis devices market during the given forecast period from 2024 to 2030.

However, complications due to anastomosis, and the increasing demand for minimally invasive or non-invasive treatment approach, among others may restrict the market growth of anastomosis devices.

Anastomosis Devices Market Segment Analysis:

In the product segment of the anastomosis devices market, the surgical staplers category is expected to have a significant revenue share in the year 2023. This is primarily owing to the rising focus of manufacturers toward developing technologically advanced surgical staplers for an improved and efficient connection of vessels and the other various advantages offered by the category.

The surgical staplers provide quick placement, minimal tissue reaction, low risk of infection, and strong wound closure in patients with cardiovascular and gastrointestinal diseases. The staplers are also available in different shapes and sizes, easing the process of closure during surgery.

Further, the increasing product launches and regulatory approvals of the anastomosis devices will aid in increasing its demand in the market. For instance, in March 2021, FDA approved Viola clamps, a less proximal anastomosis device, and a new device for clamp proximal anastomosis in coronary artery bypass grafting (CABG).

Therefore, owing to the aforementioned factors, the surgical staplers category is expected to witness considerable growth eventually contributing to the overall growth of the global anastomosis device market during the forecast period.

North America is expected to dominate the overall anastomosis devices market:

Among all the regions, North America is estimated to hold a significant revenue share in the anastomosis devices market. This can be attributed to several factors such as rising colorectum cancer cases, the presence of key market players, combined with significant advancements in product development and regulatory approvals that are acting as key factors contributing to the growth of the anastomosis devices market in the North America region during the forecast period from 2024 to 2030.

According to data from the Global Cancer Observatory 2024, it stated that in the year 2022, there were 183911 total colorectum cancer cases in the region. The same source further stated that the US accounted for 160186 colorectum cancer cases which is almost 87% of the total cases, and Canada accounted for 23725 colorectum cancer cases. Anastomosis devices are essential for reconnecting bowel segments during surgical resections. Advanced devices improve surgical precision, reduce complications, and enhance recovery, making them indispensable in managing colorectal cancer cases and expanding their market.

Additionally, in October 2024, GT Metabolic Solutions Inc., a global leader in magnetic compression anastomosis surgery, announced that the U.S. Food and Drug Administration cleared GT Metabolic's MagDI(TM) System for side-to-side duodeno-ileal (DI) anastomosis.

The prompt and well-established healthcare services and infrastructure further contribute to the growth of the regional anastomosis devices market growth. The presence of key players such as Johnson & Johnson Services, Inc., B.Braun Melsungen AG, and Medtronic with their strong distribution networks ensure widespread availability and accessibility of these devices across the region increasing their revenue shares in the market, and supportive reimbursement programs providing immense growth opportunities for the same.

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the anastomosis devices market during the forecast period from 2024 to 2030.

Anastomosis Devices Market key players:

Some the key market players operating in the anastomosis devices market include B. Braun Melsungen AG, Intuitive Surgical, BAXTER, CryoLife, Inc, Johnson & Johnson Services, Inc., Medtronic, Sinolinks Medical Innovation, Inc., microcuremed, BIOWIN PHARMACEUTICAL CO., LIMITED, Waston Medical Corporation, W. L. Gore & Associates, Inc., Hangzhou Demo Medical Technology Co., Ltd, BD, Dolphin Sutures, gpcmedical, Golden Stapler Surgical Co., Ltd., JIANGSU JOYMED TECH CO., LTD, Changzhou Haiers Medical Devices Co., Ltd, Shanghai MedEco Industry Co., Ltd, ChangZhou WeiPu Medical Devices CO., LTD, and others.

Recent Developmental Activities in the Anastomosis Devices Market:

In April 2021, Ethicon announced the global launch of a new powered surgical stapler, with gripping surface technology.
In March 2021, Johnson & Johnson launched the ECHELON Stapler, which is a powered surgical stapler designed to reduce complications in surgery through more uniform tissue compression.
In February 2021, Vascular Graft Solutions Ltd. received a receipt of marketing authorization from the FDA for VIOLA. This is a new device for clampless proximal anastomosis in CABG.

Key takeaways from the Anastomosis Devices market report study

Market size analysis for current anastomosis devices market size (2023), and market forecast for 6 years (2024 to 2030)
Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the anastomosis devices market
Various opportunities available for other competitors in the anastomosis devices market space
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current anastomosis devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for anastomosis devices market growth in the coming future?

Target audience who can be benefited from this Anastomosis Devices market report study

Anastomosis device providers
Research organizations and consulting companies
Anastomosis devices-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in anastomosis devices
Various end-users who want to know more about the anastomosis devices market and the latest developments in the anastomosis devices market

Frequently Asked Questions for the Anastomosis Devices Market:

1. What are anastomosis devices?

The anastomosis device is used for making the surgical connection between two tubular structures, such as blood vessels or loops of the intestine. An anastomosis is a surgical procedure that involves connecting two structures and is performed after the resection of an organ to connect the remaining sections.

2. What is the market for anastomosis devices?

The anastomosis devices market is projected to grow at a 5.3% CAGR during the forecast period from 2024 to 2030.

3. What are the drivers for the anastomosis devices market?

The anastomosis devices market is growing significantly due to the increasing cases of colorectum cancers, coronary artery disease among the population, clearances from regulatory bodies, and the growing burden of surgeries are factors that are expected to escalate the overall growth of the anastomosis devices market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the anastomosis devices market?

Some of the major market players operating in the anastomosis devices market include B. Braun Melsungen AG, Intuitive Surgical, BAXTER, CryoLife, Inc, Johnson & Johnson Services, Inc., Medtronic, Sinolinks Medical Innovation, Inc., microcuremed, BIOWIN PHARMACEUTICAL CO., LIMITED, Waston Medical Corporation, W. L. Gore & Associates, Inc., Hangzhou Demo Medical Technology Co., Ltd, BD, Dolphin Sutures, gpcmedical, Golden Stapler Surgical Co., Ltd., JIANGSU JOYMED TECH CO., LTD, Changzhou Haiers Medical Devices Co., Ltd, Shanghai MedEco Industry Co., Ltd, ChangZhou WeiPu Medical Devices CO., LTD, and others.

5. Which region has the highest share in the anastomosis devices market?

Among all the regions, North America is estimated to hold a significant revenue share in the anastomosis devices market. This can be attributed to several factors such as the rising colorectum cancer cases, the presence of key market players, combined with significant advancements in product development and regulatory approvals are acting as key factors that contribute to the growth of the anastomosis devices market in the North America region during the forecast period from 2024 to 2030.

1. Anastomosis Devices Market Report Introduction

1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption

2. Anastomosis Devices Market Executive Summary

2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1. The United States
4.2. Europe
4.3. Japan
4.4. China

5. Anastomosis Devices Market Key Factors Analysis

5.1. Anastomosis Devices Market Drivers
- 5.1.1. Increasing instances of chronic disorders
- 5.1.2. Rising product developmental activities
- 5.1.3. Growing number of surgeries
5.2. Anastomosis Devices Market Restraints and Challenges
- 5.2.1. Complications due to anastomosis
- 5.2.2. Increasing demand for minimally invasive treatment approaches
5.3. Anastomosis Devices Market Opportunities
- 5.3.1. Growing adoption of robot-assisted surgery
- 5.3.2. Development of bioabsorbable materials

6. Anastomosis Devices Market Porter's Five Forces Analysis

6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry

7. Anastomosis Devices Market Assessment

7.1. By Product
- 7.1.1. Surgical Staplers
- 7.1.2. Surgical Sutures
- 7.1.3. Surgical Sealants
- 7.1.4. Surgical Adhesives
7.2. By Usability
- 7.2.1. Disposable
- 7.2.2. Reusable
7.3. By Application
- 7.3.1. Cardiovascular surgery
- 7.3.2. Gastrointestinal surgery
- 7.3.3. Others
7.4. By End-User
- 7.4.1. Hospitals & clinics
- 7.4.2. Ambulatory surgical centers
- 7.4.3. Others
7.5. By Geography
- 7.5.1. North America
  - 7.5.1.1. United States Anastomosis Devices Market Size in USD million (2021-2030)
  - 7.5.1.2. Canada Anastomosis Devices Market Size in USD million (2021-2030)
  - 7.5.1.3. Mexico Anastomosis Devices Market Size in USD million (2021-2030)
- 7.5.2. Europe
  - 7.5.2.1. France Anastomosis Devices Market Size in USD million (2021-2030)
  - 7.5.2.2. Germany Anastomosis Devices Market Size in USD million (2021-2030)
  - 7.5.2.3. United Kingdom Anastomosis Devices Market Size in USD million (2021-2030)
  - 7.5.2.4. Italy Anastomosis Devices market size in USD million (2021-2030)
  - 7.5.2.5. Spain Anastomosis Devices Market Size in USD million (2021-2030)
  - 7.5.2.6. Rest of Europe Anastomosis Devices Market Size in USD million (2021-2030)
- 7.5.3. Asia-Pacific
  - 7.5.3.1. China Anastomosis Devices Market Size in USD million (2021-2030)
  - 7.5.3.2. Japan Anastomosis Devices Market Size in USD million (2021-2030)
  - 7.5.3.3. India Anastomosis Devices Market Size in USD million (2021-2030)
  - 7.5.3.4. Australia Anastomosis Devices Market Size in USD million (2021-2030)
  - 7.5.3.5. South Korea Anastomosis Devices Market Size in USD million (2021-2030)
  - 7.5.3.6. Rest of Asia-Pacific Anastomosis Devices Market Size in USD million (2021-2030)
- 7.5.4. Rest of the World (RoW)
  - 7.5.4.1. Middle East Anastomosis Devices Market Size in USD million (2021-2030)
  - 7.5.4.2. Africa Anastomosis Devices Market Size in USD million (2021-2030)
  - 7.5.4.3. South America Anastomosis Devices Market Size in USD million (2021-2030)

8. Anastomosis Devices Market Company and Product Profiles

8.1. B. Braun Melsungen AG
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. Intuitive Surgical
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. BAXTER
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. CryoLife, Inc
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. Johnson & Johnson Services, Inc.
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. Medtronic
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. Sinolinks Medical Innovation, Inc.
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. microcuremed
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. BIOWIN PHARMACEUTICAL CO., LIMITED
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. Waston Medical Corporation
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. W. L. Gore & Associates, Inc.
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy
8.12. Hangzhou Demo Medical Technology Co., Ltd
- 8.12.1. Company Overview
- 8.12.2. Company Snapshot
- 8.12.3. Financial Overview
- 8.12.4. Product Listing
- 8.12.5. Entropy
8.13. BD
- 8.13.1. Company Overview
- 8.13.2. Company Snapshot
- 8.13.3. Financial Overview
- 8.13.4. Product Listing
- 8.13.5. Entropy
8.14. Dolphin Sutures
- 8.14.1. Company Overview
- 8.14.2. Company Snapshot
- 8.14.3. Financial Overview
- 8.14.4. Product Listing
- 8.14.5. Entropy
8.15. gpcmedical
- 8.15.1. Company Overview
- 8.15.2. Company Snapshot
- 8.15.3. Financial Overview
- 8.15.4. Product Listing
- 8.15.5. Entropy
8.16. Golden Stapler Surgical Co., Ltd.
- 8.16.1. Company Overview
- 8.16.2. Company Snapshot
- 8.16.3. Financial Overview
- 8.16.4. Product Listing
- 8.16.5. Entropy
8.17. JIANGSU JOYMED TECH CO., LTD
- 8.17.1. Company Overview
- 8.17.2. Company Snapshot
- 8.17.3. Financial Overview
- 8.17.4. Product Listing
- 8.17.5. Entropy
8.18. Changzhou Haiers Medical Devices Co., Ltd
- 8.18.1. Company Overview
- 8.18.2. Company Snapshot
- 8.18.3. Financial Overview
- 8.18.4. Product Listing
- 8.18.5. Entropy
8.19. Shanghai MedEco Industry Co., Ltd
- 8.19.1. Company Overview
- 8.19.2. Company Snapshot
- 8.19.3. Financial Overview
- 8.19.4. Product Listing
- 8.19.5. Entropy
8.20. ChangZhou WeiPu Medical Devices CO., LTD
- 8.20.1. Company Overview
- 8.20.2. Company Snapshot
- 8.20.3. Financial Overview
- 8.20.4. Product Listing
- 8.20.5. Entropy